Reliability and validation of Swedish translation of Beliefs about Medication Specific (BMQ-Specific) and Brief Illness Perception Questionnaire (B-IPQ) for use in adolescents with attention-deficit hyperactivity disorder

References

• Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9(3):490–499.
   PubMed Web of Science ®Google Scholar
• Turgay A, Goodman DW, Asherson P, et al. Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry. 2012;73(02):192–201.
   PubMedGoogle Scholar
• Barkley RA, Fischer M, Smallish L, et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192–202.
   PubMed Web of Science ®Google Scholar
• Molina BS, Pelham WE, Gnagy EM, et al. Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. Alcohol Clin Exp Res. 2007;31(4):643–654.
   PubMed Web of Science ®Google Scholar
• Fridman M, Banaschewski T, Sikirica V, et al. Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe. Neuropsychiatr Dis Treat. 2017;13:373–386.
   PubMed Web of Science ®Google Scholar
• Le HH, Hodgkins P, Postma MJ, et al. Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur Child Adolesc Psychiatry. 2014;23(7):587–598.
   PubMed Web of Science ®Google Scholar
• Biederman J, Monuteaux MC, Spencer T, et al. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics. 2009;124(1):71–78.
   PubMed Web of Science ®Google Scholar
• Chang Z, Lichtenstein P, Halldner L, et al. Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatr. 2014;55(8):878–885.
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Larsson H. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med. 2013;368(8):776.
   PubMedGoogle Scholar
• Sabaté E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
   Google Scholar
• Marcus SC, Durkin M. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(5):480–489.
   PubMed Web of Science ®Google Scholar
• Hong J, Novick D, Treuer T, et al. Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia. Patient Prefer Adher. 2013;7:987–995.
   PubMed Web of Science ®Google Scholar
• Gau SS, Chen SJ, Chou WJ, et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Clin Psychiatry. 2008;69(1):131–140.
   PubMed Web of Science ®Google Scholar
• Emilsson M, Gustafsson PA, Ohnstrom G, et al. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 2016;26(5):559–571.
   PubMed Web of Science ®Google Scholar
• Ferrin M, Taylor E. Child and caregiver issues in the treatment of attention deficit-hyperactivity disorder: education, adherence and treatment choice. Future Neurol. 2011;6(3):399–413.
   Google Scholar
• Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.
   Web of Science ®Google Scholar
• Horne R, Chapman SC, Parham R, et al. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.
   PubMed Web of Science ®Google Scholar
• Petrie KJ, Broadbent E, Kydd R. Illness perceptions in mental health: issues and potential applications. J Mental Health. 2008;17(6):559–564.
   Web of Science ®Google Scholar
• Horne R. Treatment perceptions and self-regulation. In: Cameron LD, Leventhal H, editors. The self-regulation of health and illness behaviour. New York: Routledge; 2003. p. 138–153.
   Google Scholar
• Chapman SC, Barnes N, Barnes M, et al. Changing adherence-related beliefs about ICS maintenance treatment for asthma: feasibility study of an intervention delivered by asthma nurse specialists. BMJ Open. 2015;5(6):e007354.
   PubMed Web of Science ®Google Scholar
• Broadbent E, Petrie KJ, Main J, et al. The Brief Illness Perception Questionnaire. J Psychosom Res. 2006;60(6):631–637.
   PubMed Web of Science ®Google Scholar
• Jörgensen T, Andersson K, Bondesson Å, et al. The translation of the beliefs about medicines questionnaire to Swedish. Göteborg: Pharmaceutical Outcomes Research, Department of Social Medicine Göteborg University; 2003.
   Google Scholar
• Berntson E, Bernhard-Oettel C, Hellgren J, et al. Enkätmetodik. Stockholm: Natur & Kultur; 2016.
   Google Scholar
• Gatt I, West LM, Calleja N, et al. Psychometric properties of the Belief about Medicines Questionnaire (BMQ) in the Maltese language. Pharm Pract (Granada). 2017;15(1):886.
   PubMedGoogle Scholar
• Matoulkova P, Krulichova IS, Macek K, et al. Chronically III Czech patients' beliefs about medicines: the psychometric properties and factor structure of the BMQ-CZ. Drug Inf J. 2013;47(3):341.
   Google Scholar
• Alsous M, Alhalaiqa F, Abu Farha R, et al. Reliability and validity of Arabic translation of Medication Adherence Report Scale (MARS) and Beliefs about Medication Questionnaire (BMQ)-specific for use in children and their parents. PLoS One. 2017;12(2):e0171863.
   PubMed Web of Science ®Google Scholar
• Fall E, Gauchet A, Izaute M, et al. Validation of the French version of the Beliefs about Medicines Questionnaire (BMQ) among diabetes and HIV patients. Rev Eur Psychol Appl/Eur Rev Appl Psychol. 2014;64(6):335–343.
   Web of Science ®Google Scholar
• Perpiñá Tordera M, Moragón EM, Fuster AB, et al. Spanish asthma patients’ beliefs about health and medicines: validation of 2 questionnaires. Arch Bronconeumol (English Edition). 2009;45(5):218–223.
   PubMed Web of Science ®Google Scholar
• Zhang N, Fielding R, Soong I, et al. Psychometric assessment of the Chinese version of the Brief Illness Perception Questionnaire in breast cancer survivors. PLoS One. 2017;12(3):1–10.
   Web of Science ®Google Scholar
• de Raaij EJ, Schröder C, Maissan FJ, et al. Cross-cultural adaptation and measurement properties of the Brief Illness Perception Questionnaire-Dutch Language Version. Man Ther. 2012;17(4):330–335.
   PubMedGoogle Scholar
• Kossakowska MM, Stefaniak TJ. Psychometric properties for the Polish version of the Brief Illness Perception Questionnaire (Brief IPQ). Health Psychol Rep. 2017;5(1):67–83.
   Web of Science ®Google Scholar
• Bazzazian S, Besharat MA. WCPCG-2010: reliability and validity of a Farsi version of the Brief Illness Perception Questionnaire. Proc Soc Behav Sci. 2010;5:962–965.
   Google Scholar
• Timmermans I, Versteeg H, Meine M, et al. Illness perceptions in patients with heart failure and an implantable cardioverter defibrillator: dimensional structure, validity, and correlates of the Brief Illness Perception Questionnaire in Dutch, French and German patients. J Psychosom Res. 2017;97:1–8.
   PubMed Web of Science ®Google Scholar
• Karatas T, Ozen S, Kutluturkan S. Factor structure and psychometric properties of the Brief Illness Perception Questionnaire in Turkish Cancer Patients. Asia Pac J Oncol Nurs. 2017;4(1):77–83.
   PubMed Web of Science ®Google Scholar
• Diefenbach MA, Leventhal H. The common-sense model of illness representation: theoretical and practical considerations. J Soc Distress Homeless. 1996;5(1):11–38.
   Web of Science ®Google Scholar
• Leventhal H, Diefenbach M, Leventhal E. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16(2):143–163.
   Web of Science ®Google Scholar
• Leventhal H, Brissette I, Leventhal EA. The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal H, editors. The self-regulation of health and illness behaviour. New York: Routledge; 2003. p. 42–65.
   Google Scholar
• Leventhal H, Leventhal E, Contrada R. Self-regulation, health, and behavior: a perceptual-cognitive approach. Psychol Health. 1998;13(4):717–733.
   Web of Science ®Google Scholar
• Leventhal H, Benyamini Y, Brownlee S, et al. Illness representations: theoretical foundations. In: Petrie KJ, Weinman J, editors. Perceptions of health & illness. Amsterdam: Harwood Academic; 1997. p. 19–45.
   Google Scholar
• Schuz B, Wolff JK, Warner LM, et al. Multiple illness perceptions in older adults: effects on physical functioning and medication adherence. Psychol Health. 2014;29(4):442–457.
   PubMed Web of Science ®Google Scholar
• Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94–104.
   PubMed Web of Science ®Google Scholar
• Vitolins MZ, Rand CS, Rapp SR, et al. Measuring adherence to behavioral and medical interventions. Control Clin Trials. 2000;21(5):S188–S194.
   Google Scholar
• Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567.
   PubMed Web of Science ®Google Scholar
• Broadbent E. The Brief Illness Perception Questionnaire Scoring Instructions; [cited 2017 Apr 11]. Available from: http://www.uib.no/ipq/index.html2006
   Google Scholar
• Norman GR, Streiner DL. Biostatistics: the bare essentials. Hamilton: Decker; 2000.
   Google Scholar
• Field A. Discovering statistics using IBM SPSS statistics. 4th ed.; SAGA; London. 2012.
   Google Scholar
• Connelly LM. Research roundtable. Cronbach's alpha. MEDSURG Nurs. 2011;20(1):45–44.
   PubMedGoogle Scholar
• Behling O, Law KS. Translating questionnaires and other research instruments: problems and solutions. Thousand Oaks (CA): Sage; 2000.
   Google Scholar
• Weinman J, Petrie KJ, Moss-Morris R, et al. The Illness Perception Questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health. 1996;11(3):431–445.
   Web of Science ®Google Scholar
• Moss-Morris R, Weinman J, Petrie KJ, et al. The revised illness perception questionnaire (IPQ-R). Psychol Health. 2002;17(1):1–16.
   Web of Science ®Google Scholar
• Cortina JM. What is coefficient alpha? An examination of theory and applications. J Appl Psychol. 1993;78(1):98–104.
   Web of Science ®Google Scholar
• Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ. 2011;2:53–55.
   PubMedGoogle Scholar
• Granas AG, Norgaard LS, Sporrong SK. Lost in translation? Comparing three Scandinavian translations of the Beliefs about Medicines Questionnaire. Patient Educ Counsel. 2014;96(2):216–221.
   PubMed Web of Science ®Google Scholar
• BUSA BehandlingsUppföljning av Säkerställd ADHD Årsrapport 2015. BUSA BehandlingsUppföljning av Säkerställd ADHD; Socialstyrelsen; Stockholm. 2016.
   Google Scholar